PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia

L Zhou, X Jia, Y Shang, Y Sun, Z Liu… - Molecular …, 2023 - Wiley Online Library
Acute myeloid leukemia (AML) is a hematological malignancy with an alarming mortality
rate. The development of novel therapeutic targets or drugs for AML is urgently needed …
被引用次数：8 相关文章

PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.

L Zhou, X Jia, Y Shang, Y Sun, Z Liu, J Liu… - Molecular …, 2023 - europepmc.org
Acute myeloid leukemia (AML) is a hematological malignancy with an alarming mortality
rate. The development of novel therapeutic targets or drugs for AML is urgently needed …

PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia

L Zhou, X Jia, Y Shang, Y Sun, Z Liu… - Molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a hematological malignancy with an alarming mortality
rate. The development of novel therapeutic targets or drugs for AML is urgently needed …